OSE Immunotherapeutics S.A.
OSE.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €25 | €17 | €76 | €19 |
| Short-Term Investments | €16 | €0 | €0 | €0 |
| Receivables | €12 | €4 | €8 | €2 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €2 | €49 | €2 | €10 |
| Total Curr. Assets | €56 | €70 | €86 | €30 |
| Property Plant & Equip (Net) | €4 | €3 | €4 | €4 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €43 | €44 | €45 | €46 |
| Long-Term Investments | €1 | €6 | €6 | €1 |
| Tax Assets | €0 | €0 | €0 | €0 |
| Other NC Assets | €0 | €0 | €0 | €0 |
| Total NC Assets | €49 | €54 | €55 | €51 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €104 | €124 | €141 | €82 |
| Liabilities | – | – | – | – |
| Payables | €9 | €3 | €8 | €6 |
| Short-Term Debt | €6 | €8 | €4 | €7 |
| Tax Payable | €0 | €0 | €0 | €0 |
| Deferred Revenue | €1 | €0 | €3 | €0 |
| Other Curr. Liab. | €3 | €4 | €2 | €5 |
| Total Curr. Liab. | €19 | €20 | €17 | €19 |
| LT Debt | €32 | €38 | €40 | €39 |
| Deferred Rev, NC | €0 | €0 | €3 | €0 |
| Deferred Tax Liab, NC | €1 | €1 | €2 | €1 |
| Other NC Liab. | €1 | €0 | €0 | €0 |
| Total NC Liab. | €34 | €40 | €42 | €40 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €3 | €3 | €3 | €4 |
| Total Liabilities | €54 | €60 | €59 | €59 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €0 |
| Common Stock | €4 | €4 | €4 | €4 |
| Retained Earnings | -€31 | -€18 | €1 | -€23 |
| AOCI | -€0 | -€0 | -€0 | -€0 |
| Other Equity | €77 | €77 | €76 | €42 |
| Total Equity | €51 | €64 | €81 | €23 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €104 | €124 | €141 | €82 |
| Net Debt | €13 | €30 | -€32 | €27 |